<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Barnard</surname>
    <given-names>D. L.</given-names>
   </name>
   <name>
    <surname>Day</surname>
    <given-names>C. W.</given-names>
   </name>
   <name>
    <surname>Bailey</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Heiner</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Montgomery</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Lauridsen</surname>
    <given-names>L.</given-names>
   </name>
   <etal/>
  </person-group> (
  <year>2006</year>). 
  <article-title>Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.</article-title>
  <source>
   <italic>Antiviral Res.</italic>
  </source>
  <volume>71</volume>
  <fpage>53</fpage>â€“
  <lpage>63</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2006.03.001</pub-id>
  <?supplied-pmid 16621037?>
  <pub-id pub-id-type="pmid">16621037</pub-id>
 </mixed-citation>
</ref>
